A critical breakthrough in cancer study is occurring with the use of mini-antibodies to restore dysfunctional p53. This crucial cancer protector protein is frequently disabled in several kinds of malignancies, leading https://bookmarkingdepot.com/story21869809/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-approach-for-malignant-therapy